首页 › 基金 › Vivo Capital, LLC › JSPR

Vivo Capital, LLC 对 JSPR 的持仓历史

Jasper Therapeutics Inc · 医疗保健

Vivo Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 JSPR(Jasper Therapeutics Inc)5,364 股,市值约 US$4K,约占其申报组合的 0.00%,在其申报持仓中市值排名第 49 位。 Vivo Capital, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)5.36K 股
申报持仓市值$3.69K
组合权重0.00%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Vivo Capital, LLC 对 JSPR 的持仓演变

Vivo Capital, LLC 于 Q3 2026 首次披露 JSPR 持仓:5,364 股(约 US$4K)。

逐季持仓明细

季度股数金额变化
Q3 2026 5.36K $3.69K 新进

关于 JSPR 与 13F 数据

JSPR(Jasper Therapeutics Inc)属于医疗保健行业。我们追踪的基金中还有 7 只申报持有 JSPR,申报仓位最大的包括:Velan Capital Investment Management LP (US$1.1M), Carlyle Group Inc. (US$618K), ACORN CAPITAL ADVISORS, LLC (US$604K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 JSPR 的基金

查看 JSPR 的全部基金持有人 →

常见问题

How long has Vivo Capital, LLC held JSPR?

Vivo Capital, LLC has disclosed JSPR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Vivo Capital, LLC's current position in JSPR?

As of Q3 2026, Vivo Capital, LLC holds 5.36K shares of JSPR (Jasper Therapeutics Inc), valued at $3.69K, representing 0.00% of its reported portfolio and ranking #49.

Has Vivo Capital, LLC been buying or selling JSPR?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in JSPR.

Which other funds hold JSPR?

Other major institutional holders of JSPR include Velan Capital Investment Management LP, Carlyle Group Inc., ACORN CAPITAL ADVISORS, LLC, among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.